Nearly 400 people taking popular weight loss drugs like Mounjaro and Ozempic have reported serious pancreas problems, with some cases proving fatal.

Tejal Somvanshi

Mounjaro users reported 181 cases of pancreatitis with five deaths, while Ozempic and Wegovy were linked to 113 cases and one death, according to MHRA data.

Photo Credit: Sora Shimazaki (Pexels)

These GLP-1 drugs work by mimicking natural hormones that stimulate insulin production, but this mechanism might trigger dangerous pancreas inflammation in some users.

Photo source: Kindel Media (Pexels)

"The medications stimulate the pancreas to make insulin, so in an already inflamed organ, this might tip someone over the edge," explains Dr. Rekha Kumar, Cornell medicine professor.

Photo Credit: Annushka Ahuja (Pexels)

Severe abdominal pain radiating to the back, nausea, vomiting, and fever are key warning signs of pancreatitis that require immediate medical attention.

Photo Credit: SHVETS production (Pexels)

Research shows certain groups face higher risks: those with type 2 diabetes, tobacco users, and people with advanced kidney disease.

Photo Source: Kaboompics.com (Pexels)

Surprisingly, having a higher BMI (over 36) appears to provide some protection against developing pancreatitis with these medications.

Photo Source: Free Stock Range (CC0)

Julie Bishop, 55, lost two-and-a-half stone in eight weeks on Mounjaro before being hospitalized with acute pancreatitis and told to stop the medication.

Photo Source: Medium (Pexels)

The MHRA is now studying whether genetic factors influence who develops this serious side effect, encouraging affected patients to provide DNA samples.

Photo Source: FreeStockRange (CC0)

Despite the risks, manufacturers note that patient information already lists pancreatitis as an "uncommon" side effect, potentially affecting up to 1 in 100 people.

Photo Source: FreeRangeStock (CC0)